compound 36 [PMID: 21958547]   Click here for help

GtoPdb Ligand ID: 9391

Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Compound 36 is a selective and irreversible small molecule inhibitor of Bruton's tyrosine kinase (BTK) [1]. The compound is being studied for potential to treat rheumatoid arthritis, having been assessed as effective in preclinical models of the disease.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 65.76
Molecular weight 438.25
XLogP 3.69
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN(CC=CC(=O)N(C1CC2C(CC1F)N=C(c1n2cnc1)Nc1ccccc1C)C)C
Isomeric SMILES CN(C/C=C/C(=O)N(C1CC2C(CC1F)N=C(c1n2cnc1)Nc1ccccc1C)C)C
InChI InChI=1S/C24H31FN6O/c1-16-8-5-6-9-18(16)27-24-22-14-26-15-31(22)21-13-20(17(25)12-19(21)28-24)30(4)23(32)10-7-11-29(2)3/h5-10,14-15,17,19-21H,11-13H2,1-4H3,(H,27,28)/b10-7+
InChI Key KJDBCEWMSRFWQY-JXMROGBWSA-N
References
1. Kim KH, Maderna A, Schnute ME, Hegen M, Mohan S, Miyashiro J, Lin L, Li E, Keegan S, Lussier J et al.. (2011)
Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis.
Bioorg Med Chem Lett, 21 (21): 6258-63. [PMID:21958547]